Please note: At this
time, we are accepting annotation submissions
only for Pseudomonas aeruginosa strains PAO1 and LESB58.
While we are not currently
accepting annotation updates for these genomes
from individual researchers in the community,
we may receive updates from
the associated genome centers.
If you wish to make an update, please contact
the genome sequencing center first.
As P. aeruginosa research progresses, we
must continue to update this genome annotation for
it to remain a useful resource describing the blueprint
of this organism. PseudoCAP therefore obtained funds
from the Cystic Fibrosis Foundation to further develop
and maintain this P. aeruginosa genome database,
producing a continually updated version of the genome
annotation. We invite any researcher who is interested
in participating in PseudoCAP to contact
us about making a submission of a suggested
annotation update. Direct submissions through the website
are made through a web-based form system we developed
an annotation update using our Quick
Acknowledgements can be viewed in the updates log. They are given to all researchers who have made submissions to the database.
All submissions are subject to initial review.
Submissions of annotation updates therefore
do not appear immediately in the database.
Further review every 2 years at the Pseudomonas
meeting is proposed to ensure that there
is suitable feedback from the Pseudomonas
research community regarding gene names,
The database is continually being modified
to expand its flexibility and to allow for different
kinds of annotations (i.e. promoter sites) not
previously annotated. Check the What's
New section of this website for the latest
changes to the database.
Considerations when submitting a suggested annotation
update, that should be addressed in your submission
(these are required for your web-based submission):
Who are the proposed authors of the suggested
annotation change ?
What is the contact information for the corresponding
author of the change?
Is there a literature reference or genbank
accession associated with this proposed annotation
change (e.g. PubMed ID)?
Is the change based on a functional study
of P. aeruginosa PAO1, another P.
aeruginosa strain, another Pseudomonas
species, another organism, or based on a computational
analyses? We indicate this in the database by specifying a product name confidence.
Clearly summarize the basis of the proposed
change, in terms of the experiment(s) that led
to this change.
Emphasize any experimental evidence that has
led to this change and what type of experimental
evidence this was (single analysis of RNA expression
levels of a gene under a certain condition,
or array analysis using X method, or single
analysis of protein expression levels of a protein
under a certain condition). Annotation changes
proposing a new function should be based on
functional study of genes.
If you have any suggestions for improvements
to this system, don't hesitate to contact
Thank you for your participation!